Han SH, Oh GC, Kwon HM, Park CG, Kim IJ, Hwang GS, . . . Kim HS. (2018). Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: An 8-week, multicenter, randomized, open-label, Phase IV clinical study. Dove Medical Press.
Chicago Style (17th ed.) CitationHan SH, et al. Comparison of Efficacy and Safety Between Two Different Irbesartan, Generic Vs Branded, in the Treatment of Korean Patients with Mild-to-moderate Hypertension: An 8-week, Multicenter, Randomized, Open-label, Phase IV Clinical Study. Dove Medical Press, 2018.
MLA (9th ed.) CitationHan SH, et al. Comparison of Efficacy and Safety Between Two Different Irbesartan, Generic Vs Branded, in the Treatment of Korean Patients with Mild-to-moderate Hypertension: An 8-week, Multicenter, Randomized, Open-label, Phase IV Clinical Study. Dove Medical Press, 2018.